Results 191 to 200 of about 42,261,326 (330)
Early budget impact analysis of magnetic balloon technology for facilitating the completion of difficult colonoscopies. [PDF]
Rognoni C +5 more
europepmc +1 more source
An Industrial Survey of Safety Evidence Change Impact Analysis Practice
J. Vara, Markus Borg, K. Wnuk, L. Moonen
semanticscholar +1 more source
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser +14 more
wiley +1 more source
Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine
The CDK9 inhibitor AZD4573 downregulates c‐MYC and MCL‐1 to induce death of cytarabine (AraC)‐resistant AML cells. This enhances VEN + AZA‐induced cell death significantly more than any combination of two of the three drugs in AraC‐resistant AML cells.
Shuangshuang Wu +18 more
wiley +1 more source
Cost-utility and budget impact analysis of desmopressin for treating monosymptomatic nocturnal enuresis in Thai children. [PDF]
Kulthanachairojana N +4 more
europepmc +1 more source
Budget impact analysis of medicines: updated systematic review and implications
D. Faleiros +7 more
semanticscholar +1 more source
Adaptaquin selectively kills glioma stem cells while sparing differentiated brain cells. Transcriptomic and proteomic analyses show Adaptaquin disrupts iron and cholesterol homeostasis, with iron chelation amplifying cytotoxicity via cholesterol depletion, mitochondrial dysfunction, and elevated reactive oxygen species.
Adrien M. Vaquié +16 more
wiley +1 more source
Implementation and impact analysis of a clinical pharmacy ambulatory: a two-year experience. [PDF]
Mengato D +12 more
europepmc +1 more source
This study integrates transcriptomic profiling of matched tumor and healthy tissues from 32 colorectal cancer patients with functional validation in patient‐derived organoids, revealing dysregulated metabolic programs driven by overexpressed xCT (SLC7A11) and SLC3A2, identifying an oncogenic cystine/glutamate transporter signature linked to ...
Marco Strecker +16 more
wiley +1 more source

